Laura M. Periman, MD, discusses her key points regarding the benefits of using intense pulsed light (IPL)therapy to treat chalazion.Bởi EyePod: Podcasts from Ophthalmology Times

Harvey Fishman, MD, PhD, shares why intense pulsed light (IPL) therapy does wonders for his dry eye patients. Listen below!Bởi EyePod: Podcasts from Ophthalmology Times

In our latest episode, we discuss how to market your practice to draw in profitable new patients with Donna Suter, president of Donna Suter Consulting. Donna is an ophthalmic practice management expert with more than 20 years of expertise.Bởi EyePod: Podcasts from Ophthalmology Times

If you have a product idea, no matter how simple or elaborate, just go for it! You never know where it will lead you, says Joshua Mali, MD.Bởi EyePod: Podcasts from Ophthalmology Times

The latest podcast features a discussion with ARVO Executive Director Iris Rush, who discusses the upcoming annual conference.Bởi EyePod: Podcasts from Ophthalmology Times

After spending years encouraging and helping train colleagues to treat floaters, Christopher F. Wood, MD, is confident that the technologies available today will allow ophthalmologists to safely popularize the procedure and expand access to many more patients.Bởi EyePod: Podcasts from Ophthalmology Times

Whenever there’s market volatility, investors naturally become concerned about what they should do to help protect their portfolios. Ophthalmology Times' contributor John S. Grande, CFP, talks about thinking long term, and how investors may use volatility to their advantage.Bởi EyePod: Podcasts from Ophthalmology Times

In Part 2 of this EyePod episode, Rohit Varma, MD, continues the discussion on artificial intelligence (AI) and its increasing presence in diabetic retinopathy (DR) and glaucoma—and at the podiumBởi EyePod: Podcasts from Ophthalmology Times

Listen to Part 1 of our interview with Rohit Varma, MD, founding director of the newly formed Southern California Eyecare and Vision Research Institute, on artificial intelligence (AI) and its impact on the practice of ophthalmology. Why AI now, and why ophthalmology?Bởi EyePod: Podcasts from Ophthalmology Times

Nir Israeli, CEO of Sanoculis, explains the newest advances in glaucoma devices from the company.Bởi EyePod: Podcasts from Ophthalmology Times

Ahmad Aref, MD, talks about the newest glaucoma device advances from New World Medical Inc.Bởi EyePod: Podcasts from Ophthalmology Times

Chris Pulling, MicroOptx CEO, explains the newest advancements in glaucoma devices from the company.Bởi EyePod: Podcasts from Ophthalmology Times

Russ Trenary, InnFocus CEO and President, explains the newest advancements in glaucoma devices from Innfocus.Bởi EyePod: Podcasts from Ophthalmology Times

John Berdahl, MD, explains the newest advancements in glaucoma from Equinox.Bởi EyePod: Podcasts from Ophthalmology Times

Morgan Fedorchak, PhD, discusses recent data and findings from Selkie Therapeutics.Bởi EyePod: Podcasts from Ophthalmology Times

Barbara Wirostko, MD, presents data from Ohr Pharmaceutical Inc.Bởi EyePod: Podcasts from Ophthalmology Times